The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer
Clinical trial NCT05555901 · UNKNOWN
Trial details
- NCT number
- NCT05555901
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-18
- Primary completion
- 2025-09-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.